MA55291A - Procédé de fabrication d'extraits bactériens stables et leur utilisation en tant que produits pharmaceutiques - Google Patents

Procédé de fabrication d'extraits bactériens stables et leur utilisation en tant que produits pharmaceutiques

Info

Publication number
MA55291A
MA55291A MA055291A MA55291A MA55291A MA 55291 A MA55291 A MA 55291A MA 055291 A MA055291 A MA 055291A MA 55291 A MA55291 A MA 55291A MA 55291 A MA55291 A MA 55291A
Authority
MA
Morocco
Prior art keywords
manufacture
pharmaceutical products
bacterial extracts
stable bacterial
stable
Prior art date
Application number
MA055291A
Other languages
English (en)
Inventor
Jacques Bauer
Christian Pasquali
Original Assignee
Om Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Pharma Sa filed Critical Om Pharma Sa
Publication of MA55291A publication Critical patent/MA55291A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/08—Reducing the nucleic acid content
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
MA055291A 2019-03-14 2020-03-12 Procédé de fabrication d'extraits bactériens stables et leur utilisation en tant que produits pharmaceutiques MA55291A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19162912 2019-03-14

Publications (1)

Publication Number Publication Date
MA55291A true MA55291A (fr) 2022-01-19

Family

ID=65991511

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055291A MA55291A (fr) 2019-03-14 2020-03-12 Procédé de fabrication d'extraits bactériens stables et leur utilisation en tant que produits pharmaceutiques

Country Status (20)

Country Link
US (3) US11801271B2 (fr)
EP (2) EP3937957A1 (fr)
JP (2) JP2022525177A (fr)
KR (1) KR20210141546A (fr)
CN (1) CN113840615A (fr)
AU (1) AU2020235261A1 (fr)
BR (1) BR112021018006A2 (fr)
CA (1) CA3132564A1 (fr)
CL (1) CL2021002401A1 (fr)
CO (1) CO2021013677A2 (fr)
CR (1) CR20210515A (fr)
CU (1) CU20210077A7 (fr)
IL (1) IL286215B2 (fr)
MA (1) MA55291A (fr)
MX (1) MX2021010912A (fr)
PE (1) PE20212261A1 (fr)
PH (1) PH12021552089A1 (fr)
SG (1) SG11202109937UA (fr)
WO (1) WO2020182970A1 (fr)
ZA (1) ZA202106914B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019434478A1 (en) * 2019-03-14 2021-09-23 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating and/or preventing asthma, asthma exacerbations, allergic asthma and/or associated conditions with microbiota related to respiratory disorders
TW202304485A (zh) * 2021-04-12 2023-02-01 香港中文大學 用於增強免疫力的方法和組合物
WO2022233441A1 (fr) * 2021-05-07 2022-11-10 Symrise Ag Nouveau ferment bactérien provenant de l'espèce lactobacillus
KR20220152156A (ko) 2021-05-07 2022-11-15 시므라이즈 아게 락토바실러스 종의 신규한 박테리아 발효물
EP4134426A1 (fr) * 2021-08-13 2023-02-15 Symrise AG Nouveau ferment bactérien de l'espèce lactobacillus
JPWO2023120547A1 (fr) * 2021-12-22 2023-06-29
KR102763094B1 (ko) * 2022-12-09 2025-02-12 대한민국 혈관 염증 완화에 효과적인 식용 곰팡이 균주의 가수분해 물질의 제조 방법
CN118460405B (zh) * 2024-04-26 2025-03-04 广东悦创生物科技有限公司 一株副干酪乳酪杆菌xy6及其在制备调理肠胃和减肥药品中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8007911A (pt) 1979-12-06 1981-06-16 Glaxo Group Ltd Inalador aperfeicoado
DE3274065D1 (de) 1981-07-08 1986-12-11 Draco Ab Powder inhalator
GB2178965B (en) 1985-07-30 1988-08-03 Glaxo Group Ltd Devices for administering medicaments to patients
HU213221B (en) 1990-03-02 1997-03-28 Glaxo Group Ltd Inhalation device and medicine packet for device
CH685498A5 (fr) * 1992-02-14 1995-07-31 Om Lab Sa Extrait de macromolécules bactériennes, procédé pour sa préparation et composition pharmaceutique contenant cet extrait.
US5497763A (en) 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US7171965B2 (en) 2000-02-01 2007-02-06 Valois S.A.S. Breath actuated dry powder inhaler and tape dose strip
US6994083B2 (en) 2001-12-21 2006-02-07 Trudell Medical International Nebulizer apparatus and method
ES2529675T3 (es) * 2004-11-30 2015-02-24 Merial Ltd. Dispositivos de mezclado para la lisis química de células
US20080170996A1 (en) * 2006-07-28 2008-07-17 The Board Of Regents Of The University Of Texas System Compositions and Methods for Stimulation of Lung Innate Immunity
DK2114421T3 (en) * 2007-03-05 2018-04-23 Om Pharma BACTERIA EXTRACTS FOR RESPIRATORY DISORDERS AND PROCEDURES FOR PREPARING THEREOF
WO2008109667A2 (fr) 2007-03-05 2008-09-12 Om Pharma Extrait bactérien pour des troubles du tube digestif ou du tractus urinaire et procédé pour sa préparation
FR2923491B1 (fr) * 2007-11-14 2012-12-14 Deinove Sa Utilisation de bacteries pour la production de sources de bioenergie
GB0818453D0 (en) * 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
ES2356883B1 (es) 2008-07-24 2012-02-22 Bcn Peptides, S.A. Composición para el tratamiento del dolor y/o la inflamación.
WO2010027344A1 (fr) 2008-09-04 2010-03-11 Om Pharma Extraits immunomodulateurs de bactéries lactobacillus et procédés de fabrication et d’utilisation de ceux-ci
RU2425691C1 (ru) 2010-07-15 2011-08-10 ВАКЕ спол с.р.о. Аэрозольный препарат на основе апротинина для лечения вирусных респираторных инфекций
US9132243B2 (en) * 2010-07-23 2015-09-15 Tannermedico A/S Method of administering a substance to the throat
CN101979541A (zh) * 2010-10-28 2011-02-23 徐堤 一种快速共价闭合环状dna纯化试剂盒
AU2012318411A1 (en) * 2011-10-07 2014-05-29 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
SG10202012106WA (en) * 2016-12-13 2021-01-28 Defensin Therapeutics Aps Methods for treating inflammatory conditions of the lungs

Also Published As

Publication number Publication date
JP2025176089A (ja) 2025-12-03
WO2020182970A1 (fr) 2020-09-17
US11801271B2 (en) 2023-10-31
EP4234026A2 (fr) 2023-08-30
US20230346855A1 (en) 2023-11-02
JP2022525177A (ja) 2022-05-11
CO2021013677A2 (es) 2021-10-20
CU20210077A7 (es) 2022-04-07
PE20212261A1 (es) 2021-11-29
SG11202109937UA (en) 2021-10-28
CR20210515A (es) 2022-03-28
IL286215A (en) 2021-10-31
CN113840615A (zh) 2021-12-24
BR112021018006A2 (pt) 2021-11-16
CA3132564A1 (fr) 2020-09-17
EP3937957A1 (fr) 2022-01-19
EP4234026A3 (fr) 2024-07-03
IL286215B2 (en) 2025-08-01
KR20210141546A (ko) 2021-11-23
US20210401902A1 (en) 2021-12-30
PH12021552089A1 (en) 2022-05-23
ZA202106914B (en) 2023-10-25
US20250195587A1 (en) 2025-06-19
MX2021010912A (es) 2021-10-01
IL286215B1 (en) 2025-04-01
AU2020235261A1 (en) 2021-09-16
CL2021002401A1 (es) 2022-04-08

Similar Documents

Publication Publication Date Title
MA55291A (fr) Procédé de fabrication d'extraits bactériens stables et leur utilisation en tant que produits pharmaceutiques
IL287716A (en) Materials and methods for producing blood products
EP4028005A4 (fr) Inhibiteurs de cdk et leur utilisation en tant que produits pharmaceutiques
EP3733659A4 (fr) Dérivé de vinyle aromatique ou d'éthyle aromatique, procédé de préparation associé, intermédiaire, composition pharmaceutique et application
EP3486242A4 (fr) Dérivé d'oxopicolinamide, son procédé de préparation et son utilisation pharmaceutique
EP3548000A4 (fr) Compositions pharmaceutiques d'atropine
ZA202110597B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL279397A (en) New compounds and their pharmaceutical preparations for the treatment of diseases
EP3305292A4 (fr) Composition pharmaceutique d'inhibiteur de mek et procédé de préparation de celle-ci
MA52587A (fr) Composés d'azabenzimidazole et produit pharmaceutique
GB201907558D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP3401757A4 (fr) Procédé d'administration d'unité centrale de traitement et produits associés
MA53333A (fr) Formulations pharmaceutiques d'anticorps masqués
MA44286A (fr) Formulation pharmaceutique de cinéol et d'amoxicilline
MA55625A (fr) Compositions et méthodes d'administration de produits thérapeutiques
MA45158A (fr) Composition pharmaceutique comprenant de l'éteplirsen
EP3919189A4 (fr) Produit en bois et procédé de préparation correspondant
EP3329910A4 (fr) Composition pharmaceutique permettant de prévenir ou de traiter l'onychomycose et procédé de préparation associé
EP3399040A4 (fr) Procédé de préparation d'une protéine de capside de circovirus porcin de type 2 et composition pharmaceutique la contenant
EP3744711A4 (fr) Procédé de préparation de mesaconine et d'intermédiaires associés
MA50124A (fr) Procédé de préparation de tubulysines et d'intermédiaires de celles-ci
EP3503885A4 (fr) Composition pharmaceutique et procédés d'utilisation
IL285751A (en) New compounds and their pharmaceutical preparations for the treatment of diseases
EP3600324A4 (fr) Composés et compositions pour le traitement de troubles oculaires
EP4053155A4 (fr) Kératine bd-4, procédé de préparation et composition pharmaceutique et utilisation de celle-ci